HIGHLIGHTS
- who: Sebastian G. Wicha and colleagues from the Global Health Institute of Merck, Ares Trading SA, Eysins, SwitzerlandUniversity of have published the research: New In Vitro Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial Combinations, in the Journal: (JOURNAL) of 05/Dec/2022
- what: The authors show how the assay allowed the authors to identify the PK/PD relationship as a function of the concentrations of drug A and drug B. The approach suggests that animal experiments can be reduced and performed in a confirmatory fashion, thus reducing the number . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.